| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| N/A | N/A | NCI project trawling archives for outlier responses among 10,000 patients | National Cancer Institute | View |
This document is a page from a publication (likely Nautilus) discussing advances in cancer research, specifically genetic sequencing and 'outlier' cases. It highlights the work of researchers at MD Anderson and Washington University who use genomic analysis to repurpose drugs for specific genetic mutations (such as FLT3, RAD50, and TSC1). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production to the House Oversight Committee, likely related to inquiries involving Jeffrey Epstein due to his known interest in and funding of scientific research.
This document is a page from a Nautilus Education publication (likely a magazine or educational material) marked with a House Oversight Bates stamp. It details scientific research into cancer treatment 'outliers' or exceptional responders, specifically focusing on a patient treated at Memorial Sloan-Kettering by Dr. Solit using the drug everolimus. The text discusses the genetic mutations (TSC1 and NF2) involved and describes a subsequent project launched by the National Cancer Institute, led by Barbara Conley, to identify similar cases in historical clinical trial data.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity